Good Zinaida

I am a cross-trained scientist with expertise in systems biology, immunology, and oncology. My postdoctoral training with Profs. Crystal Mackall and Sylvia Plevritis at Stanford University is focused on investigating how engineered cellular immunotherapies succeed or fail in patients. Leveraging multimodal single-cell data analysis, tumor microenvironment imaging, and data integration, I aim to identify features of an ‘optimal engineered T cell’ from patient data. I earned a Ph.D. in Computational and Systems Immunology from Stanford University in 2018, where I trained with Profs. Garry Nolan and Sean Bendall. My background is in immunology (B.S. and M.S. from the University of British Columbia in Vancouver, Canada) and oncology (I worked in Discovery Oncology at Genentech and at the British Columbia Cancer Research Center for a combined 3 years). As a result of my academic training and work experiences, I became an inventor on 2 patent applications, co-authored 12 papers, and published 4 first-author manuscripts. My work and academic potential have been recognized by postdoctoral fellowships from the Parker Institute for Cancer Immunotherapy and the Stanford Cancer Institute, and I have been named an Arthur and Sandra Irving Cancer Immunology Fellow in 2022. My short-term goal is to launch an independent academic career spanning the systems biology and cancer immunotherapy fields. My long-term goal is to better understand and enhance engineered cellular immunotherapies for patients with cancer.